Longwood Fund is a Boston-based venture capital firm that creates and invests in science-based companies, particularly in the biotechnology and pharmaceuticals sectors, developing novel solutions for important medical problems.

A Boston-based VC firm that helped facilitate Solu Therapeutics' acquisition of technology from GSK.

Clinical-stage biotech Solu valued at $100M after raising $41M Series A

Longwood Fund creates & invests in science-based companies that develop novel solutions for important medical problems.Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Website: http://www

Solu Therapeutics is based in Boston, and the venture capital activities by DCVC and Longwood Fund also pertain to entities operating in the U.S.

United States

The technology platform that Solu Therapeutics acquired was licensed from GSK, a British multinational pharmaceutical company.

United Kingdom

Longwood Fund creates & invests in science-based companies that develop novel solutions for important medical problems.Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Website: http://www.longwoodfund.com.

We're a team of doctors, investors, entrepreneurs, scientists, and ...

Team

Portfolio · A new dawn for treatment of mental health ...

Portfolio

Longwood Fund is a venture capital firm dedicated to ...

About

Bio. Arielle Jackson is the Head of Corporate Communications and ...

Arielle Jackson

Bio. Dr. Westphal is co-founder and General Partner of ...

Christoph Westphal

More results from longwoodfund.com »

Longwood Fund - Home

Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Website: http://www.longwoodfund.com.

Longwood Fund

Sectors

Geography